Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Stage 1 hypertension: SBP 140-159 or DBP 90-99 Stage 2 hypertension: SBP ≥160 or DBP ≥100 For patients age 50 or older, elevated SBP is a stronger cardiovascular risk factor than elevated DBP.

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Yuan Lu, ScD, discusses a novel classification system she and colleagues developed to improve clinician adherence to ...

TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension ...

A new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial ...

Dr Ray O’Connor takes a look at the latest clinical articles on the subject of hypertension ...

Hypertension is a silent epidemic in South Africa, claiming lives without warning. Dr Vinesh Padayachy sheds light on this ...

Most of the patients had pre-existing hypertension before stroke (70.3%), and each antihypertensive class was taken by 20-30% of patients. The same spread was seen post-stroke, with 34% on an ACE ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.

interventional nephrology and advanced hypertension care. Since our inception, our goal has been focused on building a world class comprehensive training program. Our program has been continuously ...